Home › Funds › Point72 Asset Management › CTMX
Point72 Asset Management position in CTMX
CYTOMX THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)7.81M sh
Reported value held$29.29M
Portfolio Weight0.03%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 6.30M | $32.08M | New |
| Q4 2021 | 6.30M | $27.29M | Hold |
| Q1 2022 | 4.37M | $11.67M | Reduce |
| Q2 2022 | 2.75M | $5.03M | Reduce |
| Q4 2024 | 2.65M | $2.73M | New |
| Q1 2025 | 2.65M | $1.68M | Hold |
| Q2 2025 | 8.08M | $18.35M | Add |
| Q3 2025 | 4.07M | $12.98M | Reduce |
| Q4 2025 | 5.19M | $22.11M | Add |
| Q1 2026 | 7.88M | $37.01M | Add |
| Q2 2026 | 7.81M | $29.29M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTMX
- Fidelity Management & Research (FMR) 32.71M sh · $122.68M · Q2 2026
- BlackRock Inc 17.56M sh · $65.85M · Q2 2026
- Bank of America Corp 15.08M sh · $56.56M · Q2 2026
- Vanguard Group 8.48M sh · $36.11M · Q4 2025
- Wellington Management Group 5.17M sh · $19.38M · Q2 2026
- Geode Capital Management 4.68M sh · $17.55M · Q2 2026
- Two Sigma Investments 4.13M sh · $15.50M · Q2 2026
- UBS Group AG 3.47M sh · $13.01M · Q2 2026
- Citadel Advisors 3.33M sh · $12.49M · Q2 2026
- Marshall Wace 3.02M sh · $11.34M · Q2 2026
- Goldman Sachs Group 2.00M sh · $7.51M · Q2 2026